Munday Diane C, Howell Gareth, Barr John N, Hiscox Julian A
Department of Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
J Pharm Pharmacol. 2015 Mar;67(3):300-18. doi: 10.1111/jphp.12349. Epub 2014 Dec 23.
The aim of this study was to quantitatively characterise the mitochondrial proteome of airway epithelial cells infected with human respiratory syncytial virus (HRSV), a major cause of paediatric illness.
Quantitative proteomics, underpinned by stable isotope labelling with amino acids in cell culture, coupled to LC-MS/MS, was applied to mitochondrial fractions prepared from HRSV-infected and mock-infected cells 12 and 24 h post-infection. Datasets were analysed using ingenuity pathway analysis, and the results were validated and characterised using bioimaging, targeted inhibition and gene depletion.
The data quantitatively indicated that antiviral signalling proteins converged on mitochondria during HRSV infection. The mitochondrial receptor protein Tom70 was found to act in an antiviral manner, while its chaperone, Hsp90, was confirmed to be a positive viral factor. Proteins associated with different organelles were also co-enriched in the mitochondrial fractions from HRSV-infected cells, suggesting that alterations in organelle dynamics and membrane associations occur during virus infection.
Protein and pathway-specific alterations occur to the mitochondrial proteome in a spatial and temporal manner during HRSV infection, suggesting that this organelle may have altered functions. These could be targeted as part of potential therapeutic strategies to disrupt virus biology.
本研究旨在定量表征感染人呼吸道合胞病毒(HRSV)的气道上皮细胞的线粒体蛋白质组,HRSV是儿科疾病的主要病因。
采用细胞培养中氨基酸稳定同位素标记结合液相色谱-串联质谱的定量蛋白质组学方法,对感染HRSV和模拟感染的细胞在感染后12小时和24小时制备的线粒体组分进行分析。使用 Ingenuity 通路分析对数据集进行分析,并通过生物成像、靶向抑制和基因缺失对结果进行验证和表征。
数据定量表明,在HRSV感染期间,抗病毒信号蛋白聚集在线粒体上。发现线粒体受体蛋白Tom70以抗病毒方式发挥作用,而其伴侣蛋白Hsp90被证实是一种病毒阳性因子。与不同细胞器相关的蛋白质也在感染HRSV的细胞的线粒体组分中共同富集,这表明在病毒感染期间细胞器动力学和膜关联发生了改变。
在HRSV感染期间,线粒体蛋白质组在空间和时间上发生蛋白质和通路特异性改变,这表明该细胞器的功能可能发生了改变。这些改变可作为破坏病毒生物学特性的潜在治疗策略的一部分进行靶向治疗。